Bath & Body Works (BBWI) Q1 Earnings Surpass Estimates

Bath & Body Works (BBWI) reported Q1 earnings of $0.49 per share, exceeding the consensus estimate of $0.47 and up from $0.38 a year ago, representing a 4.26% surprise. Revenue for the quarter was $1.42 billion, slightly missing estimates but up from $1.38 billion year-over-year. Despite the earnings beat, BBWI shares have underperformed the S&P 500 year-to-date, and the stock holds a Zacks Rank #3 (Hold), suggesting near-term performance in line with the market.

Analysis

Bath & Body Works (BBWI) reported first-quarter earnings of $0.49 per share, surpassing the Zacks Consensus Estimate of $0.47 and increasing from $0.38 per share in the prior-year period, marking a 4.26% earnings surprise and its fourth consecutive EPS beat. However, revenues for the quarter ended April 2025, while growing to $1.42 billion from $1.38 billion year-over-year, narrowly missed the consensus estimate by 0.02%; this represents the second revenue beat in the last four quarters. Despite the earnings outperformance, BBWI's shares have significantly underperformed the broader market, declining approximately 21.4% year-to-date compared to the S&P 500's 0.1% gain. The pre-earnings estimate revision trend for BBWI was characterized as mixed, and the stock currently holds a Zacks Rank #3 (Hold), suggesting it is expected to perform in line with the market in the near future. The sustainability of any immediate price movement will largely hinge on management's commentary during the earnings call. The Retail - Miscellaneous industry, where BBWI operates, is positioned favorably, ranking in the top 14% of over 250 Zacks industries. Current consensus estimates project earnings of $0.43 per share on $1.57 billion in revenues for the upcoming quarter, and $3.55 per share on $7.5 billion in revenues for the current fiscal year.

Key Decisions for Investors

• Investors should closely scrutinize management's upcoming earnings call commentary for insights into demand trends, margin pressures, and strategic initiatives aimed at addressing the slight revenue miss and the stock's significant year-to-date underperformance.
• Given the consistent earnings per share beats counterbalanced by modest revenue performance and a Zacks Rank #3 (Hold), maintaining a neutral position on BBWI may be prudent until clearer positive catalysts or more definitive guidance on growth acceleration emerges.
• Monitor changes in consensus earnings estimates in the days following the earnings release, as these revisions will be critical indicators of shifting analyst sentiment and could heavily influence the stock's near-term trajectory.